Cargando…
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications
INTRODUCTION: There is a significant need for disease-modifying therapies to treat and prevent dementia, including Alzheimer's disease. Availability of real-world observational information and new analytic techniques to analyze large volumes of data can provide a path to aid drug discovery. MET...
Autores principales: | Kern, David M., Cepeda, M. Soledad, Lovestone, Simon, Seabrook, Guy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909196/ https://www.ncbi.nlm.nih.gov/pubmed/31872043 http://dx.doi.org/10.1016/j.trci.2019.07.012 |
Ejemplares similares
-
Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post‐Traumatic Stress Disorder
por: Kern, David M., et al.
Publicado: (2021) -
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery
por: Cepeda, M. Soledad, et al.
Publicado: (2019) -
Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease
por: Kern, David M., et al.
Publicado: (2021) -
'The unknown is frightening'
Publicado: (2020) -
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
por: Judge, Andy, et al.
Publicado: (2017)